매출 성장 + 마진 확대 + FCF 양수
Positive매출이 +15.7% 성장하면서 영업이익률이 13.2%에서 20.3%로 확대되었다. FCF도 양수를 유지하여 질적 성장이 확인된다.
Evidence
매출 YoY +15.7%영업이익률 13.2%→20.3%FCF 10,015
Genians
A263860 · KOSDAQ₩13,460+13.30%
2026-08-03 closeLoading chart…
Close
AI Insight
Why these signals fired — only backtest-proven edge, told honestly
Strong-buy signal — the real recordrecord · not a prediction
Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)
Last 30 sessions
648 picks
Next-day win rate
49.2%
Avg next-day
-0.17%
vs market
+0.72%p
Beat the market on 62.1% of picks (each pick vs its own day’s market average).
Recent publish days (next-day win rate)
07-31 0%07-30 66.7%07-29 0%07-28 45%07-27 20%07-25 36.4%07-21 55.6%07-20 53.8%07-16 53.3%07-15 50%07-14 71.4%07-13 31.2%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Valuation in its own history
PER 11.2 · PBR 2.15 — own history (2017-08~) percentiles 94/100 · 33/100
PER94/100
PBR33/100
Higher indicates lower valuation relative to its history (based on earnings and book yields).
Earnings percentiles can fluctuate for cyclical companies (including loss periods), so the book basis is shown alongside. Companies with large share buybacks can have structurally high PBR. Factual information, not investment advice.
Annual dividend
Split-adjusted annual DPS history and available grade axes
Paid 4 consecutive years · Raised 3 consecutive years · Yield 1.86% (based on 2025 payment of 250원) · 3-year growth +27.7%
Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.
Financial safety
Reference indicatorAs of 2024Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 11.87
Distress
Grey
Safe
- Altman Z''
- 11.87
- Beneish M-Score
- -2.28
- Sloan accrual
- 1.62%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Why has this company moved this way?
Auditable observations with the original numeric evidence.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
8/9Strong
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score8/9
Profitability
- Positive ROAPass
- Positive OCFPass
- Improving ΔROAPass
- Accruals (OCF > net income)Not passed
Leverage & liquidity
- Lower debtPass
- Higher current ratioPass
- No new sharesPass
Efficiency
- Higher gross marginPass
- Higher asset turnoverPass
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Cash conversion cycleWarning
현금전환주기(CCC) 3기 연속 확대 — 운전자본 경색·현금 회수 지연 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- 20.3%
- Interest coverage
- 195.5x
- Return on equity (ROE)
- 19.2%
Operating margin −5pp
TolerableInterest coverageBase 195.5x adverse case 147.2x
Return on equity (ROE)Base 19.2% adverse case 13.2%
Revenue −15%
TolerableInterest coverageBase 195.5x adverse case 166.1x
Return on equity (ROE)Base 19.2% adverse case 15%
Interest rate +2pp
TolerableInterest coverageBase 195.5x adverse case 33.3x
Return on equity (ROE)Base 19.2% adverse case 17.2%
Interest coverage limit
Current margin 20.2ppInterest coverage limit at an operating margin of 0.1%
Interest expense coverage threshold
Financials at a glance
Genians's latest results and balance sheet. The bars track the last three periods.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
5%+ major-holding disclosures
- 이동범39.36%2026-05-27 · 증감 0.00%p
- MiriCapitalManagementLLC13.89%2024-08-12 · 증감 +1.26%p
Other stocks held by the same investors
A filing-based shared-holder record, not investment advice.
- 유수홀딩스KRA000700 →
Shared holders: MiriCapitalManagementLLC
- 한국알콜KRA017890 →
Shared holders: MiriCapitalManagementLLC
- 스틱인베스트먼트KRA026890 →
Shared holders: MiriCapitalManagementLLC
- 지어소프트KRA051160 →
Shared holders: MiriCapitalManagementLLC
- 미코KRA059090 →
Shared holders: MiriCapitalManagementLLC
- 인피니트헬스케어KRA071200 →
Shared holders: MiriCapitalManagementLLC
- 가비아KRA079940 →
Shared holders: MiriCapitalManagementLLC
- 현대이지웰KRA090850 →
Shared holders: MiriCapitalManagementLLC
Connections
AI-extracted related companies · for reference
Customers
삼성SDS국내 공공기관
Same theme
제로트러스트
Recent filings
Genians's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy